Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy
Seeking Alpha
Fri, 05/17/13 - 10:48 am
Merck
Roche
R&D
Bristol-Myers Squibb
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters
Thu, 05/16/13 - 05:28 pm
Roche
M&A
Novartis
Daniel Vasella
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
Forbes
Thu, 05/16/13 - 11:07 am
Bristol-Myers Squibb
Merck
Roche
Ono Pharmaceuticals
Yervoy
nivolumab
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Roche exploring sale of diabetes device unit
Yahoo/Reuters
Wed, 05/15/13 - 05:14 pm
Roche
devices
diabetes
blood glucose monitoring
Racing Toward the Next Hepatitis C Drug Approval
Motley Fool
Wed, 05/15/13 - 09:06 am
hepatitis C
JNJ
Gilead
Merck
Roche
Vertex Pharmaceuticals
Human Immune-Boosting Cancer Drugs Seen Extending Lives
Bloomberg
Mon, 05/13/13 - 09:11 am
cancer
Merck
Bristol-Myers Squibb
Roche
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
Seeking Alpha
Fri, 05/10/13 - 08:31 am
Cellceutix
AstraZeneca
GSK
Celgene
Eli Lilly
Roche
Pfizer
Pharmacyclics
Kevetrin
cancer
3 Bio Companies Facing The Patent Cliff
Seeking Alpha
Tue, 05/7/13 - 05:31 pm
patents
patent cliff
AbbVie
BiogenIdec
Eisai
JNJ
Eli Lilly
Novartis
Sanofi
Roche
FDA warns shorter name of new Roche cancer drug may cause confusion
Yahoo/AP
Tue, 05/7/13 - 11:45 am
Roche
FDA
drug names
Kadcyla
Netupitant Results Could Roil Tesaro In May
Seeking Alpha
Mon, 05/6/13 - 10:48 am
Tesaro
Netupitant
breast cancer
ovarian cancer
niraparib
Sanofi
Roche
OPKO Health
Merck
GSK
Eisai
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha
Fri, 05/3/13 - 12:57 pm
Vical
Amgen
Bristol-Myers Squibb
OncoSec
ImmunoCellular Therapeutics
Roche
NCT00395070
melanoma
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Wed, 04/24/13 - 10:19 am
Aveo Pharmaceuticals
FDA
tivozanib
GSK
Onyx
Pfizer
renal cell carcinoma
Roche
Roche to shed 170 jobs in diagnostics restructuring
Reuters
Tue, 04/23/13 - 08:47 am
diagnostics
Roche
restructuring
Moody's sees pick-up in pharmaceutical industry M&A in 2013
Reuters
Tue, 04/23/13 - 07:52 am
M&A
Roche
Pfizer
Novartis
AstraZeneca
Top 10 pharma companies by employees
Fierce Pharma
Wed, 04/17/13 - 11:31 am
Novartis
JNJ
Sanofi
GSK
Pfizer
Abbott Laboratories
Merck
Roche
Bayer
AstraZeneca
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha
Wed, 04/17/13 - 11:07 am
Flu
H7N9
Sanofi
Novavax
Biocryst
Gilead
GSK
Merck
Roche
Inovio
Roche in hepatitis C drug deal with Ascletis in China
Reuters
Mon, 04/15/13 - 09:39 am
Roche
China
Ascletis Pharmaceuticals
hepatitis C
Pegasys
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
biotech
M&A
Otsuka
Lundbeck
Gilead
Macrogenics
Roche
Chiasma
Edison Pharma
Dainippon
Moderna
AstraZeneca
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »